Ibaraki, Japan

Kuniomi Tachibana

This inventor holds 1 USPTO granted patent. Top assignee: Nissui Pharmaceutical Co., Ltd.. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kuniomi Tachibana. Retrieved from https://idiyas.com/inventor/kuniomi-tachibana

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kuniomi Tachibana: Innovator in Anti-HIV Research

Introduction

Kuniomi Tachibana is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-HIV agents. His work has the potential to impact the lives of many individuals affected by HIV.

Latest Patents

Kuniomi Tachibana holds a patent for an anti-HIV agent. This innovation represents a crucial step forward in the fight against HIV, showcasing his dedication to improving public health through scientific research. He has 1 patent to his name, reflecting his commitment to innovation in this vital area.

Career Highlights

Tachibana is currently employed at Nissui Pharmaceutical Co., Ltd., a company known for its focus on healthcare and pharmaceutical advancements. His role at Nissui allows him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

One of his notable coworkers is Shozo Shoji. Together, they work on various projects aimed at enhancing the effectiveness of treatments for HIV and other health-related issues.

Conclusion

Kuniomi Tachibana's work in developing anti-HIV agents highlights his significant contributions to pharmaceutical innovation. His dedication to improving health outcomes through research is commendable and reflects the importance of continued innovation in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…